NIH-funded research NIH-funded research

Pentavalent meningococcal vaccine in pregnant women in Africa

Official title: Planning grant to evaluate the use of pentavalent meningococcal vaccine in pregnant women in sub-Saharan Africa

Funded at University of Maryland Baltimore · NIH-11257802 · Data updated 2026-11-12

A plan to study how safe and immune-boosting the MenFive vaccine is when given to pregnant women in sub-Saharan Africa.

More Pregnant Women research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Maryland Baltimore
NIH-funded
Lab location1 site (Baltimore, United States)
Project startAugust 20, 2026
Project endJuly 31, 2027
Funding year2026
Award (this year)$233,250
NIH project number1R34AI195140-01
Project IDNIH-11257802 on NIH RePORTER

Who could benefit from this research

Could help

Pregnant women in sub-Saharan Africa who are eligible according to the protocol.

Less likely to help

Pregnant women who do not participate or who do not meet eligibility may not benefit from the study.

What this research studies

This project will develop a Phase 4 protocol to test the MenFive pentavalent meningococcal vaccine in pregnant women in Africa, including safety monitoring and immunogenicity assessments. A multidisciplinary team will design the protocol, determine how many participants are needed, and lay out recruitment, procedures, and data analysis plans. The study aims to generate data that can support vaccine uptake and implementation during pregnancy in the region.

Why it matters

Potential benefit: If successful, the study could provide crucial safety and immune response data to support vaccinating pregnant women against meningococcal disease in Africa.

How similar studies have gone: Related vaccine studies in pregnancy have established safety monitoring frameworks, but this specific pentavalent vaccine in this population is new.

Where this research is happening

  • University of Maryland Baltimore
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Chen, Wilbur H. — University of Maryland Baltimore
  • Study coordinator: Chen, Wilbur H.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.